Market Tracker

08/18 5:16pm ET

Apricus Biosciences Inc (NASDAQ:APRI)

1.49
Delayed Data
As of Aug 18
 -0.01 / -0.67%
Today’s Change
0.86
Today|||52-Week Range
4.94
+14.62%
Year-to-Date
No recent news for Apricus Biosciences Inc.

Today’s Trading

Previous close1.50
Today’s open1.52
Day’s range1.42 - 1.54
Volume578,645
Average volume (3 months)516,679
Market cap$19.0M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+70.20%
Earnings growth (this year)+117.95%
Earnings growth (next 5 years)--
Revenue growth (last year)+19.09%
P/E ratioNM
Price/Sales1.47
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CYCCCyclacel Pharmaceuti...0.000.00%
ACSTAcasti Pharma Inc-0.01-0.76%
DMPIDelMar Pharmaceutica...+0.14+11.11%
TRPXTherapix Biosciences...+0.04+0.71%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$5.8M
Annual profit (last year)-$7.4M
Net profit margin-128.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer, CAO, Secretary &
Director
Richard W. Pascoe
Chief Business Officer &
Senior Vice President
Neil C. Morton
Corporate headquarters
San Diego, California

Forecasts